Best Practices for Type 2 Diabetes Management: Update on Guidelines and New Treatment Advances

In this interactive presentation, Vivian A. Fonseca, MD, FRCP, provides an overview of best practices for the management of type 2 diabetes with the latest guidelines and emerging treatment approaches.
Vivian A. Fonseca, MD, FRCP


Join Vivian A. Fonesca, MD, FRCP, as he shares his thoughts on the results of the phase III LEADER trial, which demonstrated a cardiovascular benefit for liraglutide in patients with type 2 diabetes who have cardiovascular disease.

Vivian A. Fonseca, MD, FRCP Released: August 15, 2016
Jointly provided by Endocrine Society and Clinical Care Options, LLC.

For questions about content or obtaining CME credit, please contact the Endocrine Society at

Supported by educational grants from
Merck & Co., Inc.
Novo Nordisk

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?